News & Resources

To Resist or Change: The Impact of the “Digital Revolution” on Medical Journal Publications

The use of social media (defined as internet-based tools that allow content-sharing among individuals and communities) by healthcare professionals (HCPs), as well as patients, has ushered in a new era of on-demand communication deemed the “digital revolution.” Gone are the days of having to wait for data dissemination through traditional methods of communication (eg, print journals). No longer do you have to wait for an influential scientific congress to provide a venue to interact with a key opinion leader in your field of interest. Through the use of digital platforms, once study results are released, HCPs and patients can access these data almost in real time. Platforms that were previously viewed as means of social engagement are now potentially influencing HCPs and healthcare decisions. As there are clear benefits to using these online platforms, medical and scientific publishing companies are making strides to keep pace with the changes brought about by digital media, while remaining loyal to traditional methods of publishing.

Shift in the medical journal publishing industry, embracing digital platforms
Some might think that the data-heavy content of medical journals would not fit the mold of the digital/social media landscape, nor would journals’ primary readers (physicians) want to engage in novel routes of communication. However, in the last few years there has been a gradual shift in the medical journal publishing industry to embrace digital platforms. A recent survey of US physicians performed by Google/Manhattan reported that physicians spend twice as much time using online resources compared with print materials when making clinical decisions, and more than 80% use a smartphone or tablet in their practice. Another published survey, by CMI/Compas, reported that although physicians still rely on medical journals and congresses as their top sources for information, they tend to utilize alternative media channels when they have limited time; 46% of oncologists reported use of online search engines for professional purposes at least 4 times a day. This trend can also be seen at the student level, where a national survey reported that more than 90% of medical students within the US use social media for professional networking and development.1

Medical journal staffs are aware that the demand for digital and mobile-friendly content is present, and with a myriad of potential online platforms at their disposal, they are taking steps to reach a new demographic of users. Social media sites can be grouped by purpose, serving functions such as

  • Social networking (Facebook, Google Plus, Twitter)
  • Professional networking (LinkedIn)
  • Media sharing (YouTube, Flickr)
  • Content production (blogs [Tumblr, Blogger] and microblogs [Twitter])
  • Knowledge/information collection (Wikipedia)

Online platforms supporting education
Online platforms that support education (peer-to-peer discussion and transfer of knowledge) and communication (personalized healthcare for patients and their families) while also being visually appealing and easy to navigate have been observed to have the most success within the medical community.

This is evident in digital media updates that have been produced by reputable medical journals, such as The New England Journal of Medicine (NEJM). Renowned for publishing groundbreaking clinical trial results, NEJM has a loyal following, thanks to the quality of its published research. NEJM has expanded its reach into social media, with an online presence that includes multiple platforms (Facebook, Twitter, and mobile apps) that allow active discussion and content-sharing among HCPs, patients, and their families. The presence of NEJM on these platforms has been very well received, with approximately 1.5 million and 490K followers on Facebook and Twitter, respectively.

Although it is unclear what success in a digital market will look like in 5 years, whether it will be based on the number of followers on a social media platform or the number of shares a post receives, we must be mindful that the overarching goal is to improve research and patient care. Irrespective of the mode of communication used (internet based vs print), there should always be a validation step to ensure the dissemination of scientifically sound and unbiased information to those involved in making healthcare decisions. Although the digital revolution is already influencing medical journal and publishing practices, the focus on optimizing patient care should remain our priority.

Reference
1. Bosslet GT, Torke AM, Hickman SE, Terry CL, Helft PR. The patient-doctor relationship and online social networks: results of a national survey. J Gen Intern Med. 2011:26(10):1168-1174.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.